Artemis Therapeutics Inc. announced earnings results for the third quarter ended September 30, 2020. For the third quarter, the company announced operating loss was USD 28,000 compared to USD 22,000 a year ago. Net loss was USD 29,000 compared to USD 24,000 a year ago. Basic loss per share from continuing operations was USD 0.01. For the nine months, operating loss was USD 104,000 compared to USD 112,000 a year ago. Net loss was USD 56,000 compared to USD 114,000 a year ago. Basic loss per share from continuing operations was USD 0.01 compared to USD 0.02 a year ago.